Paper
0
Clinical Outcomes of Patients With Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated With Tisagenlecleucel: Phase 2 ELARA 3-Year Follow- Up
Authors
Stephen Schuster,Nathan Fowler
Michael Dickinson,Joaquín Martínez‐López,Arne Kolstad,Jason Butler,Monalisa Ghosh,Leslie Popplewell,Julio Chávez,Emmanuel Bachy,Koji Kato,Hideo Harigae,Marie Kersten,Charalambos Andreadis,Peter Riedell,P. Ho,José Pérez‐Simón,Andy Chen,Loretta Nastoupil,Bastian Tresckow,Andrés Ferreri,Takanori Teshima,Piers Patten,Joseph McGuirk,Andreas Petzer,Fritz Offner,Andreas Viardot,Pier Zinzani,Ram Malladi,Aiesha Zia,Rakesh Awasthi,Inès Paule,Davide Germano,Roberto Ramos,Pei Hsu,Catherine Thieblemont,Martin Dreyling
+35 authors
,Jose Pérez‐SimónPublished
Sep 1, 2024
Show more
Save
Tip0
TipSave